INS and diabetes mellitus: The ADA has suggested that further research is needed before using non-insulin glucose lowering therapies in hospital, while UK Joint British Diabetes Societies (JBDS) guidance states that usual diabetes medications, including non-insulin therapy, can be continued unless there are specific contraindications or safety concerns [23, 24].